-+ 0.00%
-+ 0.00%
-+ 0.00%

Kanghong Pharmaceutical (002773.SZ) obtained ibutinib capsule drug registration certificate

Zhitongcaijing·11/05/2026 14:09:34
Listen to the news

Zhitong Finance App News, Kanghong Pharmaceutical (002773.SZ) issued an announcement. The company recently received the “Drug Registration Certificate” for ibutinib capsules issued by the State Drug Administration. Ibutinib is a small-molecule BTK (Bruton tyrosine kinase) inhibitor that forms covalent bonds with cysteine residues at BTK active sites, thereby inhibiting BTK's enzymatic activity. BTK is a signaling molecule for the B-cell antigen receptor (BCR) and cytokine receptor pathways. BTK activates pathways necessary for B-cell migration, chemotaxis, and adhesion through B-cell surface receptor signaling.